Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype-Reference-Cited by-同舟云学术

Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype

Published:2018-08-28 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Sowa Mandy,Kolenda Rafał,Baumgart Daniel C.,Pratschke Johann,Papp Maria,Tornai Tamas,Suchanski Jaroslaw,Bogdanos Dimitrios P.,Mytilinaiou Maria G.,Hammermann Jutta,Laass Martin W.,Conrad Karsten,Schramm Christoph,Franke Andre,Roggenbuck Dirk,Schierack Peter

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis;Weismuller;Gastroenterology,2017

2. Using GWAS to identify genetic predisposition in hepatic autoimmunity;Webb;J Autoimmun.,2016

3. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review;Boonstra;J Hepatol.,2012

4. Primary sclerosing cholangitis - a comprehensive review;Karlsen;J Hepatol.,2017

5. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis;Vesterhus;J Hepatol.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitis;Clinica Chimica Acta;2024-08

2. Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma;Digestive and Liver Disease;2024-06

3. Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity;Seminars in Immunopathology;2024-01

4. The microbiota and the gut–liver axis in primary sclerosing cholangitis;Nature Reviews Gastroenterology & Hepatology;2022-11-09

5. Serological biomarkers for management of primary sclerosing cholangitis;World Journal of Gastroenterology;2022-06-07